Survivorship, Rehabilitation, Recurrence, and Late Effects

Survivorship, Rehabilitation, Recurrence, and Late Effects

Survivorship as a phase of care

Survivorship begins at diagnosis and continues through life, but the needs often become most visible when active treatment ends. Patients may expect to feel relieved, yet many experience fatigue, fear, body image changes, financial strain, neuropathy, cognitive concerns, sexual changes, and uncertainty about follow-up. The oncology nurse validates that recovery takes time and provides a plan that explains surveillance, health promotion, late effects, medications, and who to call for symptoms.

Survivorship care plans

A survivorship care plan summarizes diagnosis, stage, biomarkers when relevant, treatments received, dates, cumulative doses or radiation fields if important, expected late effects, surveillance schedule, health maintenance, and responsible clinicians. The plan should not replace conversation. OCN practice includes confirming that the patient understands the difference between surveillance for recurrence, screening for new primary cancers, and routine primary care.

For example, a colon cancer survivor may need carcinoembryonic antigen testing and colonoscopy surveillance, but also blood pressure management, vaccinations, and age-appropriate screening.

Rehabilitation and function

Cancer rehabilitation includes physical therapy, occupational therapy, speech-language pathology, lymphedema therapy, pelvic floor therapy, vocational support, and exercise oncology resources. Rehabilitation should not be reserved for severe disability. A patient with head and neck cancer may need swallowing exercises before, during, and after radiation. A breast cancer survivor with shoulder restriction after surgery needs range-of-motion guidance and possible physical therapy. A patient with bone metastases requires activity planning that protects skeletal stability while preserving independence.

The nurse should assess activities of daily living, falls, gait, pain, fatigue, weakness, neuropathy, swallowing, continence, cognition, and ability to return to work or caregiving roles. Functional decline should be treated as a clinical problem, not an inevitable consequence of cancer.

Recurrence concerns and red flags

Fear of recurrence is common. Patients may scan their bodies for symptoms and feel anxious before surveillance visits. The nurse should provide realistic education: which symptoms to report, what follow-up tests are planned, and which symptoms are common after treatment. Dismissing fear is not therapeutic. A helpful response is, "Many survivors worry about recurrence. Let's talk about which changes need a call and what support helps when worry takes over."

Symptoms that need evaluation vary by cancer history but may include persistent new pain, neurologic deficits, unexplained weight loss, new cough or dyspnea, jaundice, persistent headaches, seizures, abdominal distension, new lumps, bleeding, or change in bowel or bladder patterns. OCN scenarios may test not attributing new focal back pain in a patient with prostate cancer to normal aging without assessment.

Late and delayed treatment effects

Late effects can appear months to years after therapy. Anthracyclines, HER2-directed therapy, and chest radiation may contribute to cardiomyopathy. Bleomycin, radiation, immunotherapy, transplant, and some targeted therapies may affect lungs. Radiation and surgery can cause fibrosis, bowel dysfunction, strictures, xerostomia, dental problems, and lymphedema. Platinum agents, taxanes, vinca alkaloids, and proteasome inhibitors can cause peripheral neuropathy.

Endocrine effects include premature menopause, infertility, thyroid dysfunction, adrenal issues, metabolic changes, osteoporosis, and sexual dysfunction. Immunotherapy can cause delayed immune-related adverse events affecting skin, bowel, liver, endocrine organs, lungs, kidneys, and nerves.

Secondary malignancy risk may follow prior radiation, alkylating agents, topoisomerase II inhibitors, or inherited predisposition. Survivors also need infection prevention, vaccination review, and attention to cardiovascular risk factors because some treatments increase long-term cardiac and vascular risk.

Coordination with primary care

Survivorship care works best when oncology and primary care share responsibility. Oncology often guides recurrence surveillance and treatment-specific late effects. Primary care manages general prevention, chronic disease, vaccinations, and noncancer screening. The nurse helps clarify ownership so the patient does not hear, "That is not our department," when a symptom or health need arises.